Translational research fuels discovery at Baylor Scott & White Research Institute

Baylor Scott & White Research Institute (BSWRI) is well known for its diverse research portfolio. The program actively maintains nearly 2,000 active and enrolling projects across more than 50 medical specialties each year, including initiatives supported by its translational research program. The program is focused on driving innovation by working with clinical teams across the Baylor Scott & White Health System to develop new medicines and diagnostic tests. The translational research team’s approach to discovery of “bench-to-bedside- and- back-to-bench” allows BSWRI to continue to be a major contributor to advancements in medical science.

Read more

Baylor Scott & White researchers identify a novel site for islet cell transplantation

Patients experiencing the intractable pain of chronic pancreatitis may be candidates for total pancreatectomy followed by autologous islet cell transplantation (TPIAT). This innovative procedure has been documented to be very effective in controlling pain and restoring insulin secretion in a large number of patients. Baylor University Medical Center, (Baylor Dallas) part of Baylor Scott & White Health, has performed more than 200 successful islet cell transplants, placing it among the top five centers in the United States based on total case volume of this procedure.

Read more

Baylor Scott & White Annette C. and Harold C. Simmons Transplant Institute hosts conference on donation after circulatory death

While the number of organ donations after circulatory death (DCD) continues to grow in the United States and worldwide, it is yet to be accepted universally as a viable option to serve patients on the waiting list. Donation after circulatory death was the topic of the 7th Innovations in Transplant Summit, hosted April 22 and 23 by Baylor University Medical Center (Baylor Dallas), part of Baylor Scott & White Health.

Read more

Baylor Scott & White researchers launch study to examine the impact of exercise on “long COVID” and COVID-19 recovery

The Centers for Disease Control and Prevention (CDC) has reported that an estimated 140 million Americans have been infected with the SARS-CoV-2 virus based on data collected from blood tests taken through January 2022. Many of these Americans are still feeling the after-effects of the virus known as post-acute sequelae of SARS-CoV-2 (PASC), or “long COVID.” The cases of PASC are becoming so common that lawmakers introduced a bill to fund research into the long-term effects of the disease and expand treatment resources for people experiencing them.

Read more